IRIX
IRIX
NASDAQ · Health Care

Iridex Corp

$1.15
+0.01 (+0.88%)
As of Jun 30, 10:47 PM ET ·
Financial Highlights (FY 2026)
Revenue
57.50M
Net Income
-4,843,016
Gross Margin
36.5%
Profit Margin
-8.4%
Rev Growth
-2.6%
D/E Ratio
0.76
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 36.5% 36.5% 56.3% 56.3%
Operating Margin -4.9% -4.4% 13.1% 16.3%
Profit Margin -8.4% -8.0% 13.2% 10.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 57.50M 59.02M 9.46M 8.84M
Gross Profit 20.99M 21.54M 5.33M 4.98M
Operating Income -2,805,941 -2,592,226 1.24M 1.45M
Net Income -4,843,016 -4,474,147 1.25M 954.2K
Gross Margin 36.5% 36.5% 56.3% 56.3%
Operating Margin -4.9% -4.4% 13.1% 16.3%
Profit Margin -8.4% -8.0% 13.2% 10.8%
Rev Growth -2.6% -2.6% +21.4% +18.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 4.51M 4.51M 6.66M 8.89M
Total Equity 5.94M 5.94M 19.95M 18.01M
D/E Ratio 0.76 0.76 0.33 0.49
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -2,234,811 -2,179,296 2.05M 1.75M
Free Cash Flow 641.3K 670.3K